The Liver Meeting® 2018 – The 70th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)

Event Date: November 8 - 12, 2019

Event Location: Booth: 1224, John B Hynes Memorial Convention Center, 900 Boylston St, Boston, MA 02115

Diapharma will attend and exhibit at The Liver Forum and The Liver Meeting (AASLD) this year. Booth 1224. Please click here to schedule a meeting with us or email us directly.

About The Liver Meeting

The Liver Meeting® provides a forum for the exchange of basic, translational and clinical research in diseases of the liver and biliary tract, and in liver transplantation. The Liver Meeting® creates an arena for the presentation and interchange of opinions on state-of-the-art care and management of the full spectrum of patients with liver disease.


  • Bile Acid Signaling and Cholestatic Liver Diseases
  • Drug-Induced Liver Injury: Assessing Risk and Predicting Outcome (Hepatotoxicity)
  • NAFLD Progression: A Cross Talk with Microbiome (Nonalcoholic Fatty Liver Disease)
  • Acute and Chronic Kidney Failure in Cirrhosis: Mechanisms to Management (Acute on Chronic Liver Failure and Portal Hypertension)
  • AASLD / ILTS Transplant Course
  • The Critically Ill Patient and Challenges in Liver Transplantation
  • AASLD / ASGE Endoscopy Course
  • New Endoscopic Frontiers in Liver Disease
  • Clinical Research Workshop
  • Microbiome as a Model of Clinical Research: From Stool to Study to Treatment
  • Special Interest Group Programming
  • Improving the Care Continuum for Chronic HCV Infection in 2019 (Hepatitis C)
  • Novel Approaches to Study and Treat Liver Fibrosis (Liver Fibrosis)
  • AASLD / NASPGHAN Pediatric Symposium
  • Acute Liver Failure
  • Clinical Hepatology (Clinical Practice)
  • Updates and Controversies in HBV: Management, HCC Surveillance and Emerging Therapies (Hepatitis B)
  • Regenerative Medicine and the Bio-Artificial Liver (Liver Cell Biology in Hepatic Diseases
  • Current Trends in Liver Regeneration and Repair
  • Precision Hepatology in Clinical Practice
  • Liver Transplantation for NASH: Optimizing Outcomes
  • A New Era of Genomics and Biomarkers in Hepatocellular Carcinoma
  • Clinical vs Science in Personalizing Immunosuppression
  • Emerging Therapies and Current Clinical Trials for Alcoholic Hepatitis (Alcoholic Liver Disease )
  • Social Innovation: Solution-Based Responses to Disparities in Liver Diseases and Liver Transplantation
  • Defining the Role of Hepatologists in Value-Based Care
  • Obesity, Metabolic Syndrome and HCC (Hepatobiliary Neoplasia)
  • Multi-Disciplinary Approach in Reducing Readmissions (Hepatology Associates)
  • Acute on Chronic Liver Failure
  • Genetic Susceptibility to Drug-Induced Liver
  • New AASLD Guidelines: A Summary of New Recommendations for HCC, PBC and ALD
  • Distributed Hepatocytes in Liver Homeostasis and Regeneration
  • Microelimination of Viral Hepatitis
  • Molecular Pathogenesis and Hepatocellular Carcinoma


liver biomarker assay test kit ELISA

About the AASLD

The mission of the American Association for the Study of Liver Diseases (AASLD) is to advance the science of hepatology and to promote liver health.

AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. AASLD fosters research that leads to improved treatment options for millions of liver disease patients. AASLD advances the science and practice of hepatology through meetings such as The Liver Meeting®, educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies.


AASLDFacebook | Twitter | LinkedIn | YouTube | Instagram | Invitation Postcard